CTRP9与糖尿病视网膜病变关系的研究进展
Research Progress of the Relationship between CTRP9 and Diabetic Retinopathy
DOI: 10.12677/ACM.2021.1111721, PDF,    科研立项经费支持
作者: 朱晓燕, 金 涛：甘肃中医药大学，第一临床医学院(甘肃省人民医院)，甘肃 兰州；刘 勤*：甘肃中医药大学，第一临床医学院(甘肃省人民医院)，甘肃 兰州；甘肃省人民医院，眼科，甘肃 兰州；白惠玲, 张 书：甘肃省人民医院，眼科，甘肃 兰州
关键词: CTRP9；脂联素；糖尿病视网膜病变；CTRP9； Adiponectin； Diabetic Retinopathy
摘要: 糖尿病视网膜病变在糖尿病微血管病变中是最为主要的病变，也是其最严重的并发症之一，如果不能够及时治疗将可能导致终身失明，而糖尿病视网膜病变的发病机制比较复杂，目前尚未完全阐述清楚，主要由炎症、氧化应激和细胞凋亡引起。补体C1q肿瘤坏死因子相关蛋白9 (C1q/TNF-related protein 9, CTRP9)是最接近脂联素旁系同源物的脂肪细胞因子，以往的研究表明CTRP9主要在心血管疾病的研究中发挥着重要作用，近年来有研究发现它在糖尿病视网膜病变中也发挥有益的作用。本文就CTRP9与糖尿病视网膜病变关系的研究进展做一综述。
Abstract: Diabetic retinopathy is the most important lesion in diabetic microangiopaemia and one of its most serious complications. If not treated in time, it may lead to lifelong blindness. However, the pathogenesis of diabetic retinopathy is complicated and has not been fully explained yet. It is mainly caused by inflammation, oxidative stress and apoptosis. C1q/TNF-related protein 9 (CTRP9) is the adipocytokine closest to the adiponectin parafunctional homolog. Previous studies have shown that CTRP9 mainly plays an important role in the study of cardiovascular diseases. In recent years, it has been found that it also plays a beneficial role in diabetic retinopathy. This article reviews the research progress of the relationship between CTRP9 and diabetic retinopathy.
文章引用：朱晓燕, 刘勤, 金涛, 白惠玲, 张书. CTRP9与糖尿病视网膜病变关系的研究进展[J]. 临床医学进展, 2021, 11(11): 4912-4918. https://doi.org/10.12677/ACM.2021.1111721

参考文献

[1] Cheung, N., Mitchell, P. and Wong, T.Y. (2010) Diabetic Retinopathy. The Lancet, 376, 124-136. [Google Scholar] [CrossRef] 
[2] Schmidt, A.M. (2018) Highlighting Diabetes Mellitus: The Epidemic Continues. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, e1-e8. [Google Scholar] [CrossRef] 
[3] Hammes, H.P. (2018) Diabetic Retinopathy: Hyperglycaemia, Oxidative Stress and Beyond. Diabetologia, 61, 29-38. [Google Scholar] [CrossRef] [PubMed]
[4] Wong, G.W., Krawczyk, S.A., Kitidis-Mitrokostas, C., et al. (2009) Identification and Characterization of CTRP9, a Novel Secreted Glycoprotein, from Adipose Tissue That Reduces Serum Glucose in Mice and Forms Heterotrimers with Adiponectin. The FASEB Journal, 23, 241-258. [Google Scholar] [CrossRef] [PubMed]
[5] 蒋慰, 鲁燕. C1q/肿瘤坏死因子相关蛋白9与代谢相关疾病的基础研究进展[J]. 中国糖尿病杂志, 2018(26): 427-430.
[6] 张铭. 内皮抑素抑制糖尿病视网膜新生血管生成中的研究进展[J]. 中华实验眼科杂志, 2017, 35(5): 474-477.
[7] 温积权, 曹永葆, 汪怿, 等. 羟苯磺酸钙联合血栓通对糖尿病视网膜病变致患者视野缺损的临床疗效[J]. 中国临床药理学杂志, 2016, 32(1): 12-14.
[8] Eshaq, R.S., Aldalati, A.M.Z., Alexander, J.S., et al. (2017) Diabetic Retinopathy: Breaking the Barrier. Pathophysiology, 24, 229-241. [Google Scholar] [CrossRef] [PubMed]
[9] Xu, J., Chen, L.J., Yu, J., et al. (2018) Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy. Cellular Physiology and Biochemistry, 48, 705-717. [Google Scholar] [CrossRef] [PubMed]
[10] Barber, A.J. (2003) A New View of Diabetic Retinopathy: A Neurodegenerative Disease of the Eye. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 283-290. [Google Scholar] [CrossRef] 
[11] Kowluru, R.A., Kowluru, A., Mishra, M., et al. (2015) Oxidative Stress and Epigenetic Modifications in the Pathogenesis of Diabetic Retinopathy. Progress in Retinal and Eye Research, 48, 40-61. [Google Scholar] [CrossRef] [PubMed]
[12] Brownlee, M. (2005) The Pathobiology of Diabetic Complications: A Unifying Mechanism. Diabetes, 54, 1615-1625. [Google Scholar] [CrossRef] [PubMed]
[13] Durham, J.T., Dulmovits, B.M., Cronk, S.M., et al. (2015) Pericyte Chemomechanics and the Angiogenic Switch: Insights into the Pathogenesis of Proliferative Diabetic Retinopathy? Investigative Ophthalmology & Visual Science, 56, 3441-3459. [Google Scholar] [CrossRef] [PubMed]
[14] Anderson, D.R. and Davis, E.B. (1996) Glaucoma, Capillaries and Pericytes. 5. Preliminary Evidence That Carbon Dioxide Relaxes Pericyte Contractile Tone. Ophthalmologica, 210, 280-284. [Google Scholar] [CrossRef] [PubMed]
[15] Li, W., Liu, X., Yanoff, M., et al. (1996) Cultured Retinal Capillary Pericytes Die by Apoptosis after an Abrupt Fluctuation from High to Low Glucose Levels: A Comparative Study with Retinal Capillary Endothelial Cells. Diabetologia, 39, 537-547. [Google Scholar] [CrossRef] 
[16] Lorenzi, M., Montisano, D.F., Toledo, S., et al. (1986) High Glucose Induces DNA Damage in Cultured Human Endothelial Cells. Journal of Clinical Investigation, 77, 322-325. [Google Scholar] [CrossRef] 
[17] Schäffler, A. and Buechler, C. (2012) CTRP Family: Linking Immunity to Metabolism. Trends in Endocrinology & Metabolism, 23, 194-204. [Google Scholar] [CrossRef] [PubMed]
[18] Kopp, A., Bala, M., Weigert, J., et al. (2010) Effects of the New Adiponectin Paralogous Protein CTRP-3 and of LPS on Cytokine Release from Monocytes of Patients with Type 2 Diabetes Mellitus. Cytokine, 49, 51-57. [Google Scholar] [CrossRef] [PubMed]
[19] Seldin, M.M., Tan, S.Y. and Wong, G.W. (2014) Metabolic Function of the CTRP Family of Hormones. Reviews in Endocrine and Metabolic Disorders, 15, 111-123. [Google Scholar] [CrossRef] [PubMed]
[20] Schmid, A., Kopp, A., Hanses, F., et al. (2012) The Novel Adipokine C1q/TNF-Related Protein-3 Is Expressed in Human Adipocytes and Regulated by Metabolic and Infection-Related Parameters. Experimental and Clinical Endocrinology & Diabetes, 120, 611-617. [Google Scholar] [CrossRef] [PubMed]
[21] Liang, C., Liu, Y., Gao, L., et al. (2018) Effect of Lipid Factor CTRP9 on Myocardial Remodeling Induced by Isoproterenol in Mice. Scimago Journal & Country Rank, 98, 3025-3031.
[22] Zhao, D., Feng, P., Sun, Y., et al. (2018) Cardiac-Derived CTRP9 Protects against Myocardial Ischemia/Reperfusion Injury via Calreticulin-Dependent Inhibition of Apoptosis. Cell Death & Disease, 9, 723. [Google Scholar] [CrossRef] [PubMed]
[23] Kambara, T., Ohashi, K., Shibata, R., et al. (2012) CTRP9 Protein Protects against Myocardial Injury Following Ischemia-Reperfusion through AMP-Activated Protein Kinase (AMPK)-Dependent Mechanism. Journal of Biological Chemistry, 287, 18965-18973. [Google Scholar] [CrossRef] 
[24] Chen, J.Y., Lei, S.Y., Li, T.T., et al. (2020) CTRP9 Induces iNOS Expression through JAK2/STAT3 Pathway in Raw 264.7 and Peritoneal Macrophages. Biochemical and Biophysical Research Communications, 523, 98-104. [Google Scholar] [CrossRef] [PubMed]
[25] Jung, C.H., Lee, M.J., Kang, Y.M., et al. (2014) Association of Serum C1q/TNF-Related Protein-9 Concentration with Arterial Stiffness in Subjects with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 99, E2477-E2484. [Google Scholar] [CrossRef] [PubMed]
[26] Wolf, R.M., Steele, K.E., Peterson, L.A., et al. (2016) C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated with Obesity and Decrease Following Weight Loss Surgery. The Journal of Clinical Endocrinology & Metabolism, 101, 2211-2217. [Google Scholar] [CrossRef] [PubMed]
[27] Wei, Z., Lei, X., Petersen, P.S., et al. (2014) Targeted Deletion of C1q/TNF-Related Protein 9 Increases Food Intake, Decreases Insulin Sensitivity, and Promotes Hepatic Steatosis in Mice. The American Journal of Physiology—Endocrinology and Metabolism, 306, E779-E790. [Google Scholar] [CrossRef] [PubMed]
[28] Sun, Y., Yi, W., Yuan, Y., et al. (2013) C1q/Tumor Necrosis Factor-Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation. Circulation, 128, S113-S120. [Google Scholar] [CrossRef] 
[29] Huang, C., Zhang, P., Li, T., et al. (2019) Overexpression of CTRP9 Attenuates the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice. Molecular and Cellular Biochemistry, 455, 99-108. [Google Scholar] [CrossRef] [PubMed]
[30] Asada, M., Morioka, T., Yamazaki, Y., et al. (2016) Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction. Journal of Diabetes Research, 2016, Article ID: 8624313. [Google Scholar] [CrossRef] [PubMed]
[31] Hu, H., Li, W., Liu, M., et al. (2020) C1q/Tumor Necrosis Factor-Related Protein-9 Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice. DNA and Cell Biology, 39, 938-948. [Google Scholar] [CrossRef] [PubMed]
[32] Moradi, N., Fadaei, R., Emamgholipour, S., et al. (2018) Association of Circulating CTRP9 with Soluble Adhesion Molecules and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease. PLoS ONE, 13, e0192159. [Google Scholar] [CrossRef] [PubMed]
[33] Yan, W., Guo, Y., Tao, L., et al. (2017) C1q/Tumor Necrosis Factor-Related Protein-9 Regulates the Fate of Implanted Mesenchymal Stem Cells and Mobilizes Their Protective Effects against Ischemic Heart Injury via Multiple Novel Signaling Pathways. Circulation, 136, 2162-2177. [Google Scholar] [CrossRef] 
[34] Yu, X.H., Zhang, D.W., Zheng, X.L., et al. (2018) C1q Tumor Necrosis Factor-Related Protein 9 in Atherosclerosis: Mechanistic Insights and Therapeutic Potential. Atherosclerosis, 276, 109-116. [Google Scholar] [CrossRef] [PubMed]
[35] Li, W., Ma, N., Liu, M.X., et al. (2019) C1q/TNF-Related Protein-9 Attenuates Retinal Inflammation and Protects Blood-Retinal Barrier in db/db Mice. European Journal of Pharmacology, 853, 289-298. [Google Scholar] [CrossRef] [PubMed]
[36] Adamiec-Mroczek, J. and Oficjalska-Mlynczak, J. (2008) Assessment of Selected Adhesionmolecule and Proinflammatory Cytokine Levels in the Vitreous Body of Patients with Type 2 Diabetes-Role of the Inflammatory-Immune Process in the Pathogenesis of Proliferative Diabetic Retinopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 246, 1665-1670. [Google Scholar] [CrossRef] [PubMed]
[37] Chernykh, V.V., Varvarinsky, E.V., Smirnov, E.V., et al. (2015) Proliferative and Inflammatory Factors in the Vitreous of Patients with Proliferativediabetic Retinopathy. Indian Journal of Ophthalmology, 63, 33-36. [Google Scholar] [CrossRef] [PubMed]
[38] True, A.L., Rahman, A. and Malik, A.B. (2000) Activation of NF-kappaB Induced by H2O2 and TNF-Alpha and Its Effects on ICAM-1 Expression in Endothelial Cells. AJP Lung Cellular and Molecular Physiology, 279, 302-311. [Google Scholar] [CrossRef] 
[39] Jung, C.H., Lee, M.J., Kang, Y.M., et al. (2016) C1q/TNF-Related Protein-9 Inhibits Cytokine-Induced Vascular Inflammation and Leukocyte Adhesiveness via AMP-Activated Protein Kinase Activationin Endothelial Cells. Molecular and Cellular Endocrinology, 419, 235-243. [Google Scholar] [CrossRef] [PubMed]
[40] Matter, K. and Balda, M.S. (2003) Signalling to and from Tight Junctions. Nature Reviews Molecular Cell Biology, 4, 225-236. [Google Scholar] [CrossRef] [PubMed]
[41] Gardner, T.W. (1995) Histamine, ZO-1 and Increased Blood-Retinal Barrier permeability in Diabetic Retinopathy. Transactions of the American Ophthalmological Society, 93, 583-621.
[42] Aveleira, C.A., Lin, C.M., Abcouwer, S.F., et al. (2010) TNF-Alpha Signals through PKCzeta/NF-kappaB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability. Diabetes, 59, 2872-2882. [Google Scholar] [CrossRef] [PubMed]
[43] Cheng, Y., Qi, Y., Liu, S., et al. (2020) C1q/TNF-Related Protein 9 Inhibits High Glucose-Induced Oxidative Stress and Apoptosis in Retinal Pigment Epithelial Cells through the Activation of AMPK/Nrf2 Signaling Pathway. Cell Transplant, 29, 1-11. [Google Scholar] [CrossRef] [PubMed]
[44] 王欣荣, 吕伯昌, 李海燕. 血清补体C1q肿瘤坏死因子相关蛋白3、补体C1q肿瘤坏死因子相关蛋白9水平对糖尿病视网膜病变患者的影响及相关性研究[J]. 中国医药导报, 2015, 12(26): 8-11.

为你推荐